This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jul;15(7):795-8.

doi: 10.1080/14760584.2016.1189331.

The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection

Punnee Pitisuttithum¹, Alain Bouckenooghe²

Affiliations

Affiliations

¹ a Faculty of Tropical Medicine , Vaccine Trial Centre, Mahidol University , Bangkok , Thailand.
² b Clinical Sciences and Medical Affairs Asia , Sanofi Pasteur , Singapore , Singapore.

PMID: 27171845
DOI: 10.1080/14760584.2016.1189331

Editorial

The first licensed dengue vaccine: an important tool for integrated preventive strategies against dengue virus infection

Punnee Pitisuttithum et al. Expert Rev Vaccines. 2016 Jul.

. 2016 Jul;15(7):795-8.

doi: 10.1080/14760584.2016.1189331.

Authors

Punnee Pitisuttithum¹, Alain Bouckenooghe²

Affiliations

¹ a Faculty of Tropical Medicine , Vaccine Trial Centre, Mahidol University , Bangkok , Thailand.
² b Clinical Sciences and Medical Affairs Asia , Sanofi Pasteur , Singapore , Singapore.

PMID: 27171845
DOI: 10.1080/14760584.2016.1189331

No abstract available

Keywords: CYD-TDV; Dengue; health planning; preventive strategies; vaccine.

PubMed Disclaimer

Similar articles

A recombinant live attenuated tetravalent vaccine for the prevention of dengue.
Guy B, Noriega F, Ochiai RL, L'azou M, Delore V, Skipetrova A, Verdier F, Coudeville L, Savarino S, Jackson N. Guy B, et al. Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1335201. Epub 2017 Jun 7. Expert Rev Vaccines. 2017. PMID: 28590795 Review.
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
Dayan GH, Galán-Herrera JF, Forrat R, Zambrano B, Bouckenooghe A, Harenberg A, Guy B, Lang J. Dayan GH, et al. Hum Vaccin Immunother. 2014;10(10):2853-63. doi: 10.4161/21645515.2014.972131. Hum Vaccin Immunother. 2014. PMID: 25483647 Free PMC article. Clinical Trial.
Targets and strategies for vaccine development against dengue viruses.
Wang WH, Urbina AN, Lin CY, Yang ZS, Assavalapsakul W, Thitithanyanont A, Lu PL, Chen YH, Wang SF. Wang WH, et al. Biomed Pharmacother. 2021 Dec;144:112304. doi: 10.1016/j.biopha.2021.112304. Epub 2021 Oct 8. Biomed Pharmacother. 2021. PMID: 34634560
Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults.
Kirstein J, Douglas W, Thakur M, Boaz M, Papa T, Skipetrova A, Plennevaux E. Kirstein J, et al. BMC Infect Dis. 2018 Sep 21;18(1):475. doi: 10.1186/s12879-018-3389-x. BMC Infect Dis. 2018. PMID: 30241510 Free PMC article. Clinical Trial.
Serostatus-dependent performance of the first licensed dengue vaccine: implications for travellers.
Wilder-Smith A. Wilder-Smith A. J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay057. J Travel Med. 2018. PMID: 30016457 No abstract available.

See all similar articles

Cited by

Whole inactivated dengue virus-loaded trimethyl chitosan nanoparticle-based vaccine: immunogenic properties in ex vivo and in vivo models.
Jearanaiwitayakul T, Sunintaboon P, Chawengkittikul R, Limthongkul J, Midoeng P, Chaisuwirat P, Warit S, Ubol S. Jearanaiwitayakul T, et al. Hum Vaccin Immunother. 2021 Aug 3;17(8):2793-2807. doi: 10.1080/21645515.2021.1884473. Epub 2021 Apr 16. Hum Vaccin Immunother. 2021. PMID: 33861177 Free PMC article.
Population dynamics of engineered underdominance and killer-rescue gene drives in the control of disease vectors.
Edgington MP, Alphey LS. Edgington MP, et al. PLoS Comput Biol. 2018 Mar 23;14(3):e1006059. doi: 10.1371/journal.pcbi.1006059. eCollection 2018 Mar. PLoS Comput Biol. 2018. PMID: 29570717 Free PMC article.
Innate immune escape by Dengue and West Nile viruses.
Gack MU, Diamond MS. Gack MU, et al. Curr Opin Virol. 2016 Oct;20:119-128. doi: 10.1016/j.coviro.2016.09.013. Epub 2016 Oct 25. Curr Opin Virol. 2016. PMID: 27792906 Free PMC article. Review.
Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice.
Scott CAP, Amarilla AA, Bibby S, Newton ND, Hall RA, Hobson-Peters J, Muller DA, Chappell KJ, Young PR, Modhiran N, Watterson D. Scott CAP, et al. Viruses. 2021 Sep 15;13(9):1843. doi: 10.3390/v13091843. Viruses. 2021. PMID: 34578424 Free PMC article.
Future risk of dengue fever to workforce and industry through global supply chain.
Nakano K. Nakano K. Mitig Adapt Strateg Glob Chang. 2018;23(3):433-449. doi: 10.1007/s11027-017-9741-4. Epub 2017 Mar 16. Mitig Adapt Strateg Glob Chang. 2018. PMID: 32214871 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information